LUPIN2,074.00

Lupin Ltd.

· Pharma & Health
₹ CrorePeersSUNPHARMACIPLADRREDDYALKEMFORTISAUROPHARMALAURUSLABSMANKINDMcap ₹94,823 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment4,898.65,148.25,449.15,449.1
+ Capital Work-in-Progress595.7355.5695.2695.2
+ Goodwill2,325.02,232.62,658.52,658.5
+ Other Intangibles1,654.72,338.62,886.32,886.3
+ Intangibles under Development176.9161.2321.0321.0
+ Investments (Equity Method)26.927.729.029.0
+ Non-current Investments200.859.663.663.6
+ Long-term Loans3.63.32.12.1
+ Other Non-current Financial Assets119.41,293.51,451.61,451.6
Non-current Financial Assets323.81,356.31,517.31,517.3
+ Deferred Tax Assets302.5559.1564.7564.7
+ Other Non-current Assets245.5227.2216.5216.5
Total Non-current Assets10,549.512,406.314,337.514,337.5
Current Assets
+ Inventories4,953.95,476.46,083.36,083.3
+ Current Investments846.91,059.13,577.13,577.1
+ Trade Receivables4,692.15,497.16,604.16,604.1
+ Cash & Cash Equivalents983.31,543.74,167.74,167.7
+ Other Bank Balances219.31,598.61,485.21,485.2
+ Short-term Loans2.65.02.92.9
+ Other Current Financial Assets638.5332.1563.0563.0
Current Financial Assets7,382.610,035.716,400.016,400.0
+ Other Current Assets1,070.61,251.91,542.71,542.7
Total Current Assets13,447.716,798.624,027.424,027.4
Total Assets23,997.229,204.938,364.838,364.8
Equity
+ Equity Share Capital91.191.391.491.4
+ Other Equity / Reserves14,199.217,112.222,356.822,356.8
Equity — Owners of Parent14,290.317,203.522,448.322,448.3
+ Minority Interest83.290.965.165.1
Total Equity14,373.517,294.422,513.422,513.4
Liabilities
+ Borrowings — Non-current0.01,766.21,643.41,643.4
+ Other Non-current Financial Liab311.6315.9547.5547.5
Non-current Financial Liabilities311.62,082.12,190.92,190.9
+ Provisions — Non-current375.4436.1532.7532.7
+ Deferred Tax Liabilities245.9226.4218.8218.8
+ Other Non-current Liabilities189.4204.5257.8257.8
Non-current Liabilities1,122.22,949.13,200.23,200.2
+ Borrowings — Current2,669.93,310.44,266.84,266.8
+ Trade Payables2,958.12,958.24,173.14,173.1
+ Other Current Financial Liab775.5839.31,333.11,333.1
Current Financial Liabilities6,403.57,107.99,773.19,773.1
+ Provisions — Current524.9273.2561.2561.2
+ Current Tax Liabilities429.1440.2668.0668.0
+ Other Current Liabilities1,143.91,140.11,648.91,648.9
Current Liabilities8,501.58,961.412,651.212,651.2
Total Liabilities9,623.711,910.515,851.515,851.5
Total Equity & Liabilities23,997.229,204.938,364.838,364.8
Assets — additional as-filed lines
+ Current Tax Assets40.634.61.51.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current85.9157.3157.3
+ Dues to Other Creditors — Current2,872.34,015.84,015.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.